United States
Germany
Japan
United Kingdom
China
Nppb (NM_008726) Mouse Tagged ORF Clone Lentiviral Particle
CAT＃: MR200586L3V
- LentiORF®
-
Lenti ORF particles, Nppb (Myc-DDK-tagged) - Mouse natriuretic peptide type B (Nppb), 200ul, >10^7 TU/mL
Need custom lentivirus service?
Get a free quote
CNY 7,410.00
货期*
详询
规格
Product images
经常一起买 (2)
Specifications
| Product Data | |
| Product Name | Nppb (NM_008726) Mouse Tagged ORF Clone Lentiviral Particle |
| Synonyms | AA408272; BNF; BNP |
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| ACCN | NM_008726 |
| ORF Size | 363 bp |
| Sequence Data |
The ORF insert of this clone is exactly the same as(MR200586).
|
| OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
| OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
| Reference Data | |
| RefSeq | NM_008726.4 |
| RefSeq Size | 797 bp |
| RefSeq ORF | 366 bp |
| Locus ID | 18158 |
| Gene Summary | This gene encodes a secreted protein that belongs to the family of natriuretic peptides. Its precursor protein is processed to generate the active mature peptide. The mature peptide is a cardiac hormone that plays a role in ventricular remodeling as well as blood pressure regulation. Mice lacking this gene exhibit cardiac fibrosis. In humans this gene is associated with congestive heart failure, low bone-mineral density and postmenopausal osteoporosis. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2013] |
Documents
| Product Manuals |
| FAQs |
| SDS |
Resources
You may also need
Customer
Reviews
Loading...
